Clear Trail Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$408K Sell
4,729
-851
-15% -$75.6K 0.06% 126
2026
Q2
$505K Sell
5,580
-305
-5% -$25.6K 0.08% 120
2026
Q1
$471K Sell
5,885
-122
-2% -$10.1K 0.08% 113
2025
Q4
$512K Buy
+6,007
New +$493K 0.12% 86

Other funds holding EW

Clear Trail Advisors's EW Position: Q3 2026 in Review

Clear Trail Advisors reduced its Edwards Lifesciences (EW) stake by 15% in Q3 2026, selling an estimated $75.6K and leaving 4,729 shares worth $408K. The position accounts for 0.06% of the portfolio, ranked #126.

Clear Trail Advisors first reported a position in EW in Q4 2025 and has held it in 4 quarters since. The position peaked at $512K in Q4 2025. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Clear Trail Advisors held 4,729 shares of Edwards Lifesciences worth $408K as of Q3 2026.
  • Clear Trail Advisors sold 851 Edwards Lifesciences shares in Q3 2026, an estimated $75.6K.
  • Edwards Lifesciences made up 0.06% of Clear Trail Advisors's portfolio in Q3 2026, its #126 holding.
  • Clear Trail Advisors first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 4 quarters since.
  • Clear Trail Advisors's Edwards Lifesciences position peaked at $512K in Q4 2025.
  • 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Clear Trail Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.